Fresenius Medical EBITDA vs. Revenue
0H9X Stock | 43.88 0.72 1.61% |
For Fresenius Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Fresenius Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Fresenius Medical Care utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Fresenius Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Fresenius Medical Care over time as well as its relative position and ranking within its peers.
Fresenius |
Fresenius Medical Care Revenue vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Fresenius Medical's current stock value. Our valuation model uses many indicators to compare Fresenius Medical value to that of its competitors to determine the firm's financial worth. Fresenius Medical Care is number one stock in ebitda category among its peers. It is rated second in revenue category among its peers totaling about 7.96 of Revenue per EBITDA. At this time, Fresenius Medical's Total Revenue is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fresenius Medical's earnings, one of the primary drivers of an investment's value.Fresenius Revenue vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Fresenius Medical |
| = | 2.42 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Fresenius Medical |
| = | 19.24 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Fresenius Revenue vs Competition
Fresenius Medical Care is rated second in revenue category among its peers. Market size based on revenue of Industrials industry is presently estimated at about 53.48 Billion. Fresenius Medical totals roughly 19.24 Billion in revenue claiming about 36% of equities under Industrials industry.
Fresenius Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Fresenius Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Fresenius Medical will eventually generate negative long term returns. The profitability progress is the general direction of Fresenius Medical's change in net profit over the period of time. It can combine multiple indicators of Fresenius Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last Reported | Projected for Next Year | ||
Interest Income | 423.2 M | 401.9 M | |
Operating Income | 2.1 B | 2 B | |
Income Before Tax | 1.7 B | 1.7 B | |
Net Income Applicable To Common Shares | 606.1 M | 961.4 M | |
Net Income | 499 M | 946.2 M | |
Income Tax Expense | 292.5 M | 334.6 M | |
Change To Netincome | -112.8 M | -118.4 M |
Fresenius Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Fresenius Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Fresenius Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Fresenius Medical's important profitability drivers and their relationship over time.
Use Fresenius Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fresenius Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fresenius Medical will appreciate offsetting losses from the drop in the long position's value.Fresenius Medical Pair Trading
Fresenius Medical Care Pair Trading Analysis
The ability to find closely correlated positions to Fresenius Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fresenius Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fresenius Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fresenius Medical Care to buy it.
The correlation of Fresenius Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fresenius Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fresenius Medical Care moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fresenius Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Fresenius Medical position
In addition to having Fresenius Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Driverless Cars Thematic Idea Now
Driverless Cars
It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.